Search results
Researchers reveal how protein modifications power T cells
Newswise· 3 days agoIn our cells, molecules called phosphate groups are constantly attaching to—or detaching...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma -...
Benzinga· 2 days agoNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop...
CBS 47 Fresno· 6 hours agoAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc. (NASDAQ: PSTX, President and CEO: Kristin Yarema, "Poseida") today announced that ...
New method rapidly reveals how protein modifications power T cells
Medical Xpress· 3 days ago"Small kinds of chemical 'ornaments' are added or removed from proteins in a very rapid fashion, and these modifications change how a protein interacts with other biomolecules," says La Jolla ...
Magic Johnson Details How He’s Defied the Odds Since 1991 HIV Diagnosis: 'I’ve Done My Part'...
People via Yahoo News· 4 days ago“Every time I go to the doctor and my T-cell count is off the charts, that's when I know I’m good,”...
Do cutting-edge CAR-T-cell therapies cause cancer? What the data say
Nature· 2 days agoRegulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is...
Q1 2024 TG Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoWe recently entered into a partnership with Precision BioSciences to acquire worldwide license to Precision's either cell and allogeneic CD19 CAR T-cell ...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 7 days agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 2 days agoResearchers answered this question in a joint study conducted by the NUS Yong Loo Lin School of Medicine (NUS Medicine) and Duke-NUS Medical School. With parental consent and assent from child ...
Repertoire partners with Bristol Myers for autoimmune vaccines By Investing.com
Investing.com· 3 days agoRepertoire Immune Medicines, a biotech firm specializing in T cell targeted immune therapies, has...
